Biosimilars and Rheumatoid Arthritis: A New Era of Treatment

Apr 16, 2025

Living with rheumatoid arthritis can be challenging, especially with the high cost of biologic treatments. New research from the University of Manchester shows that biosimilars—lower-cost alternatives to biologic drugs—are just as safe and effective for managing RA. This breakthrough could make life-changing treatments more affordable and accessible to more patients.

Reported by

Reviewed by

You May Also Like